Rita Andrade

Dr. Rita Andrade

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
RARita Andrade
Rita Andrade
ICIsabel Carreira
Isabel Carreira
ICIsabel Marques Carreira
Isabel Marques Carreira
José TralhãoJosé Tralhão
José Tralhão
Cholangiocarcinoma (CCA) is a rare biliary tract tumor with high malignancy. CCA is the second most common primary hepatobiliary cancer after hepatocarcinoma. Despite its rarity, the incidence of CCA is steadily increasing globally. Most patients with CCA are asymptomatic in the early stages, resulting in a late-stage diagnosis and poor prognosis. Finding reliable biomarkers is essential to improve CCA’s early diagnosis and survival rate. Non-coding RNAs (ncRNAs) are non-protein coding RNAs produced by genomic transcription. This includes microRNAs, long non-coding RNAs, and circular RNAs. ncRNAs have multiple functions in regulating gene expression and are crucial for maintaining normal cell function and developing diseases. Many studies have shown that aberrantly expressed ncRNAs can regulate the occurrence and development of CCA. ncRNAs can be easily extracted and detected through tumor tissue and liquid biopsies, representing a potential tool for diagnosing and prognosis CCA. This review will provide a detailed update on the diagnostic and prognostic potentials of lncRNAs and cirRNAs as biomarkers in CCA.

2 February 2025 in Cancers
Verified
Journal Article
Open access
PDF file
RARita Andrade
Rita Andrade
JRJudith PÉREZ ROJAS
Judith PÉREZ ROJAS
SSSílvia Gomes da Silva
Sílvia Gomes da Silva
MMMigla Miskinyte
Migla Miskinyte
MQMargarida Quaresma
Margarida Quaresma
JCJoana Cardoso
Joana Cardoso
Background/Objectives: Hepatocellular carcinoma (HCC) is a major cause of cancer-related deaths rising worldwide. This is leading to an increased demand for liver transplantation (LT), the most effective treatment for HCC in its initial stages. However, current patient selection criteria are limited in predicting recurrence and raise ethical concerns about equitable access to care. This study aims to enhance patient selection by refining the HepatoPredict (HP) tool, a machine learning-based model that combines molecular and clinical data to forecast LT outcomes. Methods: The updated HP algorithm was trained on a two-center dataset and assessed against standard clinical criteria. Its prognostic performance was evaluated through accuracy metrics, with additional analyses considering tumor heterogeneity and potential sampling bias. Results: HP outperformed all clinical criteria, particularly regarding negative predictive value, addressing critical limitations in existing selection strategies. It also demonstrated improved differentiation of recurrence-free and overall survival outcomes. Importantly, the prognostic accuracy of HP remained largely unaffected by intra-nodule and intra-patient heterogeneity, indicating its robustness even when biopsies were taken from smaller or non-dominant nodules. Conclusions: These findings support the usage of HP as a valuable tool for optimizing LT candidate selection, promoting fair organ allocation and enhancing patient outcomes through integrated analysis of molecular and clinical data.

13 January 2026 in International Surgery Journal
Verified
Journal Article
Open access
PDF file
RARita Andrade
Rita Andrade
MAMaria João Amaral
Maria João Amaral
MSMarco Serôdio
Marco Serôdio
IPInês Prior
Inês Prior
JTJosé Guilherme Tralhão
José Guilherme Tralhão
Ciliated hepatic foregut cysts (CHFC) are rare and typically benign lesions of the liver derived from an embryonic remnant of foregut epithelium. Patients are almost always asymptomatic and mostly incidentally found on radiologic studies. Radiographic imaging is usually insufficient for diagnosis and definitive diagnosis is made through histology. It is important to consider this condition in the differential diagnosis of liver lesions, particularly those located in the subcapsular region of the segment 4. Usual diagnostic uncertainty and a malignant potential that cannot be totally excluded, surgical excision should be considered. We describe a case of a 76-year-old male with an atypical cystic mass in segment 4 of the liver who underwent a laparoscopic resection. Histology revealed a ciliated hepatic foregut cyst.

28 October 2021 in International Surgery Journal
Verified
Journal Article
Open access
PDF file
AAAna C. Almeida
Ana C. Almeida
AGAndreia Guimarães
Andreia Guimarães
MAMaria João Amaral
Maria João Amaral
RARita Andrade
Rita Andrade
ABAntónio Bernardes
António Bernardes
Treatment of postoperative gastric fistula complicated by local and systemic infection is difficult and controversial, particularly when treating obese patients with multiple prior surgical procedures. A 41-year-old male patient was transferred to our hospital to be admitted in the Intensive Care Unit with respiratory failure and postoperative sepsis, after being submitted to bariatric surgery. He had been through four subsequent surgical procedures: 1- a laparoscopic sleeve gastrectomy; 2- an exploratory laparotomy for unproven suspected subphrenic abscess; 3- a laparotomy with splenectomy and peritoneal drainage for splenic and peri-splenic abscess; 4-celiotomy and lavage for purulent peritonitis. Due to persistent clinical and analytical deterioration, and suspicion of left subphrenic abscess and digestive fistula, we proceeded to: identification and drainage of the abscess, adhesiolysis, identification of fistula orifice at the cardiac incisure (methylene blue and perioperative endoscopy), placement of a Pezzer tube for directed and controlled fistulization, Shirley’s drain in the subphrenic space for continuous lavage, jejunostomy for enteral nutrition. Under clinical and imaging control (esophageal transit, fistulography and computed tomography with water-soluble contrasts) he was started on a water diet 2 months after and the Shirley’s drain was later removed. Patient was discharged two and a half months after the intervention, maintaing the Pezzer tube and under enteral nutrition by jejunostomy. Oral feeding started in the 3rd postoperative month and jejunostomy and Pezzer probes were removed. Patient was asymptomatic at seven-month postoperative outpatient appointment.